Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09WHM
|
|||
| Former ID |
DIB006442
|
|||
| Drug Name |
DU-29894
|
|||
| Indication | Psychotic disorder [ICD-11: 6A20-6A25] | Discontinued in Phase 1 | [1] | |
| Company |
Solvay Pharmaceuticals BV
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H22FN3O
|
|||
| Canonical SMILES |
C1CN(CCN1CC2=CC=C(N2)C3=CC=C(C=C3)F)C4=CC=CC5=C4OC=C5
|
|||
| InChI |
1S/C23H22FN3O/c24-19-6-4-17(5-7-19)21-9-8-20(25-21)16-26-11-13-27(14-12-26)22-3-1-2-18-10-15-28-23(18)22/h1-10,15,25H,11-14,16H2
|
|||
| InChIKey |
PGNHBJGIQAEIHD-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 115464-77-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001422) | |||
| REF 2 | A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers. Br J Clin Pharmacol. 1995 Jan;39(1):7-14. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.